Stephen N. Keith

Stephen N. Keith, M.D., M.S.P.H. is a business leader, pharmaceutical and biotech executive, entrepreneur, and clinician. Dr. Keith has been instrumental in launching VBI and is experienced in raising capital for public-private life science companies, investment banking venture capital. He is a board-certified pediatrician with over 20 years of considerable clinical experience in academic, hospital, and outpatient settings. Former Chief Executive Officer of Vivacelle Bio, Inc. Former President, Antex Biologies (Vaccines and Antibodies), now a wholly-owned subsidiary of Emergent BioSolutions (NYSE;2015: Total Revenue US$523 Million & EBITDA US$130 Million) and Panacea Pharmaceuticals (Cancer and Central Nervous System Drugs)(Series E 15 US $15 Million closed in December 2015.